{
 "context": "The following article called 'Dendreon Jumps as More Doctors Prescribe Cancer Therapy' was published on 2012-11-02. The body of the article is as follows:\n    \nDendreon Corp. (DNDN)  rose the most in nine\nmonths after announcing a third-quarter loss that was less than\nanalysts\u2019 estimates and saying more doctors are using its\nprostate cancer drug Provenge.  The biotechnology company jumped 16 percent to $4.47 at the\nclose in  New York , its biggest single-day advance since Feb. 6.\nThe Seattle-based drugmaker had a loss of 33 cents a share,\nexcluding a restructuring charge. Analysts had expected a loss\nof 82 cents, according to the average of 22 estimates compiled\nby Bloomberg.  Urologists prescribing Provenge grew 14 percent in the\nquarter, Dendreon said today in a statement. The number of\noncologists doing so fell by less than 1 percent, an improvement\nfrom an 8 percent slide in the second quarter. The medicine\naccounted for two-thirds of Dendreon\u2019s sales last year and faces\ncompetition from new drugs from  Johnson & Johnson (JNJ)  and  Medivation\nInc. (MDVN)   \u201cWe delivered strong growth in urology and have continued\nto improve results in oncology,\u201d Chief Executive Officer John\nH. Johnson said in a statement today.  The quarter\u2019s net loss of $154.9 million, or $1.04 a share,\ncompared with a net loss of $147.1 million, or $1, a year\nearlier, Dendreon said.  To contact the reporter on this story:\nAlex Nussbaum in New York at \n anussbaum1@bloomberg.net   To contact the editor responsible for this story:\nReg Gale at \n rgale5@bloomberg.net\n\n    The day before the article was published, the stock price of Johnson & Johnson was 55.40244674682617 and the day after the article was published, the stock price of Johnson & Johnson was ",
 "expected": "54.852291107177734",
 "date": "2012-11-02",
 "ticker": "JNJ",
 "company": "Johnson & Johnson",
 "url": "http://www.bloomberg.com/news/2012-11-02/dendreon-jumps-as-more-doctors-turn-to-provenge-seattle-mover.html"
}